EP2598242B1 - Apparatus for separating components of a sample liquid - Google Patents
Apparatus for separating components of a sample liquid Download PDFInfo
- Publication number
- EP2598242B1 EP2598242B1 EP11730285.1A EP11730285A EP2598242B1 EP 2598242 B1 EP2598242 B1 EP 2598242B1 EP 11730285 A EP11730285 A EP 11730285A EP 2598242 B1 EP2598242 B1 EP 2598242B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- channels
- channel
- area
- separating device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims description 49
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 238000013022 venting Methods 0.000 claims description 7
- 238000009423 ventilation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0621—Control of the sequence of chambers filled or emptied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502723—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by venting arrangements
Definitions
- the present invention relates to a device for the treatment and preferably examination of sample liquid, in particular blood, according to the preamble of claim 1 and such a method.
- the present invention is particularly concerned with microfluidic systems and devices.
- the following explanations therefore relate in particular to devices in which capillary forces act and, in particular, are decisive for the function.
- Devices are known in which blood is filtered as sample liquid by means of a flat separating device.
- the filtrate or the permeate is taken up in a chamber which adjoins the separator on the flat side and is discharged laterally via a connecting channel.
- the channel has a relation to the chamber substantially smaller cross-section.
- fluidic structures such as columns or the like, in order to achieve the most uniform distribution and accordingly good discharge or discharge via the channel.
- fluidic structures are disadvantageous in terms of a much larger dead volume.
- Similar devices for blood separation are for example from WO 2005/119211 A1 and the WO 2009/106331 A2 known.
- the flat, thin separating device can be slightly deformed transversely to its surface extension, in particular in the adjoining the separator downstream chamber.
- the US5135719 A discloses a method of separating plasma and red blood cells wherein a low pressure filter (specifically, a microfiber glass filter) is disposed in a flow path between an inlet and a reaction area. Under the filter, the plasma collects in a collecting area and flows through capillary forces driven solely by capillary forces to the reaction area. At the reaction area a vent is connected.
- a low pressure filter specifically, a microfiber glass filter
- the EP 1500937 A1 discloses an instrument for analyzing fluidic samples wherein a separation sheet separates solid components from the fluid and the filtered liquid distributes from an underlying reservoir into radially outgoing channels. Each of these channels has a branch connected to a vent and an expanded reaction area containing a solid, liquid-soluble reagent.
- the present patent application is based on the object of specifying a device and a method for the treatment and preferably examination of sample liquid, in particular blood, wherein an optimization of the fluidic throughput is made possible in a simple manner and / or while avoiding an excessively increased dead volume.
- a basic idea of the present invention is that the sample liquid from the downstream of the separator - especially directly and / or flat - subsequent chamber not only one, but at least two channels and accordingly not only one, but at least two lateral Derive drainage areas.
- a significantly higher throughput or a significantly larger amount be derived on sample liquid.
- This can be explained in particular by the fact that a better discharge from different areas of the substantially flat or planar chamber and thus also from different areas of the areal separator takes place. Accordingly, the permeability of the sample liquid separator is better utilized over a wider range than is otherwise the case with only a small channel channel.
- the sample liquid derived from the two channels that is to say the sample liquid filtered by the separating device, such as blood plasma or blood serum, can then be supplied, for example, to a common examination area or alternatively to two separate examination areas.
- the channels are preferably brought together in a connecting chamber or connecting line, which is particularly preferably vented in order to avoid undesired gas or air influences, in particular in the case of channels filling at different rates.
- Fig. 1 shows in a schematic section a proposed device 1 for the treatment and preferably examination of sample liquid 2, in particular blood or other human or animal body fluid.
- the apparatus 1 has a planar separating device 3 for treating the sample liquid 2, in particular for separating off constituents, such as particles or cells, from the sample liquid 2.
- the separator 3 is used for filtering. It preferably has a filter element, a membrane or the like. on.
- the separator 3 may be constructed one or more layers. It is preferably flat or flat.
- the separating device 3 by a membrane, as in the WO 2009/106331 A2 described, formed or provided with it.
- the device 1 has a chamber 4 for receiving sample liquid 2 that has flowed through the separating device 3.
- the chamber 4 thus receives sample fluid 2 treated or filtered by the separating device 3, such as blood plasma or blood serum.
- the chamber 4 preferably connects flat side and directly to the separator 3 downstream.
- the chamber 4 is arranged below the separating device 3.
- the separating device 3 is larger in area than the chamber 4 is formed.
- the separating device 3 protrudes laterally beyond the chamber 4, in the illustrated embodiment particularly preferably on all sides.
- the sample liquid 2 is guided free of side walls in the chamber 4. This is achieved in the illustrated example, in particular, that adjoins a bottom 5 of the chamber 4 laterally a capillary stop, which is particularly preferably formed by a circumferential or laterally adjoining trench 6.
- a capillary stop which is particularly preferably formed by a circumferential or laterally adjoining trench 6.
- the chamber 4 in particular between the bottom 5 of the chamber 4 on the one hand and the opposite region of Separator 3 formed. Due to the small distance between these two opposite surfaces, the sample liquid 2 is preferably kept free of side walls in the chamber 4 by capillary forces.
- the trench 6 forms by its abrupt cross-sectional enlargement - ie its greater depth relative to the chamber height (distance of the bottom 5 of the separator 3) - the capillary stop.
- the device 1 preferably has a carrier 7, an associated cover 8 and / or a receiving element 9.
- the carrier 7 is preferably plate-like and / or rigid.
- the carrier 7 is preferably made of plastic and / or by injection molding.
- the carrier 7 preferably has microfluidic structures for the sample liquid 2 and / or deaeration structures or the like. on, which will be discussed later. These structures are preferably - at least partially - covered by the cover 8.
- the cover 8 is preferably made of plastic and / or designed as a film.
- the cover 8 is preferably laminated to the carrier 7 or glued or otherwise connected thereto.
- the cover 8 preferably extends at least substantially over the entire surface or continuously over the carrier 7.
- the receiving element 9 preferably serves to hold the separating device 3 and / or to receive the sample liquid 2, such as a blood drop, as in FIG Fig. 1 indicated.
- the receiving element 9 has for this purpose, for example, a receiving area 10, such as an opening, opening or the like., On.
- the separator 3 may, for example, in an annular shoulder or the like. be held on the receiving element 9.
- the separating device 3 is connected, for example, by gluing, clamping and / or welding or in any other suitable manner with the receiving element 9 and / or the carrier 7 or the cover 8 or held thereof.
- the receiving element 9 is arranged on the cover 8 or connected thereto.
- the receiving element 9 can also be directly connected to the carrier 7 and / or be formed by this.
- the trench 6 is connected via a vent channel 11 to the environment.
- the vent channel 11 is formed in the carrier 7.
- the sample liquid 2 that has passed through the separator 3 is also referred to as the sample liquid 2.
- Fig. 1 is merely indicated schematically that the sample liquid 2 upstream of the separator 3 may include, for example, schematically indicated larger components that are no longer contained in the sample liquid 2 after flowing through the separator 3 - ie in the chamber 4. It is in particular in the chamber 4 and further downstream then to the treated or filtered sample liquid 2 or its permeate. The further description is to be understood in particular in this sense.
- Fig. 2 shows a schematic plan view of a preferred fluidic structure for the discharge of the sample liquid 2 from the chamber 4 of the proposed device 1 according to a first embodiment. In particular, the shows Fig. 2 in a schematic plan view of the carrier 7 without cover 8, receiving element 9, separator 3, sample liquid. 2
- the device 1 has a first channel 12, which laterally adjoins the chamber 4 in a first outflow region 13.
- the device 1 further has at least one second channel 14, which laterally adjoins the chamber 4 in a second discharge region 15.
- the device 1 thus has a plurality of channels 12, 14 and discharge regions 13, 15 for the discharge of sample liquid 2 from the chamber 4.
- the channels 12, 14 have a relation to the chamber 4 a substantially smaller cross-section.
- the channels 12, 14 preferably each have a minimum or average cross section or a cross section in the region of the respective outflow region 13/15, which is less than 20%, preferably less than 15%, in particular less than 10%, particularly preferably less than 5 % of the maximum cross section of the chamber 4 is.
- Maximum cross-section of the chamber 4 is to be understood here in particular as a product of chamber height with the average or maximum diameter of the bottom 5.
- the channels 12, 14 and drainage areas 13, 15 are preferably offset at the edge of the chamber 4 or arranged or connected on opposite sides. Accordingly, the discharge of sample liquid 2 from the chamber 4 from different areas or at different locations, whereby the throughput of the device 1 and the separation or filter performance of the device 1 and the separator 3 can be significantly increased in a surprisingly simple manner, as already explained at the beginning.
- more than two channels and drainage areas for the discharge of sample liquid 2 from the chamber 4 to the chamber 4 may be laterally connected.
- the throughput or the discharge of sample liquid 2 can be further increased.
- a cross-type arrangement of four channels and outflow areas on the chamber 4 is possible.
- Fig. 2 It can be seen that the lateral trench 6 is divided by the drainage regions 13, 15 into two trench sections, which surround the chamber 4 or its bottom 5, in particular like an annular segment.
- the outflow regions 13, 15 form web-like or bridge-like connections via the trench 6 to the chamber 4 or its bottom 5.
- the channels 12, 14 are preferably formed by groove-like or groove-like depressions, in particular in the carrier 7.
- the channels 12, 14 extend over the drainage regions 13, 15, particularly preferably into the chamber 4 or the bottom 5 and / or under the separating device 3.
- the channels 12, 14 end open towards the separating device 3 in their respective end region .
- the cover 8, which otherwise covers the channels 12, 14, may also, as required, extend into or over the drainage regions 13, 15 and / or into the chamber 4 or over the bottom 5, in particular to form tongue-like protuberances 16, as in FIG Fig. 2 indicated by dash-dotted lines.
- the channels 12, 14 extend at least substantially to one another in the middle of the chamber 4 or in the bottom 5, as in FIG Fig. 2 indicated by dashed lines.
- the device 1 has a preferably chamber-like examination area 17 for the examination of sample liquid 2 derived from the chamber 4.
- both the first channel 12 and the second channel 14 are fluidly connected to the examination area 17 in the illustrated example. This can optionally be done directly or optionally via a connecting line 18 and / or a connecting chamber 19, as in Fig. 2 indicated.
- the connection line 18 and the connecting chamber 19 are thus in particular optional and can also be omitted if necessary.
- the two channels 12 and 14 initially combine and the sample liquid 2 derived from the chamber 4 is then forwarded to the examination region 17 via the common connection line 18.
- the optional connecting chamber 19 is preferably formed. As I said, but this is only optional and can be omitted if necessary.
- a vent for the examination area 17 and / or for the connecting line 18 and / or connecting chamber 19 is provided.
- the venting of connecting line 18 and connecting chamber 19 is preferably carried out in the illustrated embodiment by a vent channel 20, for example, directly or indirectly connected to the environment and / or may be in gas exchange and / or with the examination area 17 and / or trench 6 for venting or can be connected.
- the venting provided is preferably designed such that, even with differently fast filling of the channels 12, 14 with sample liquid 2 derived from the chamber 4, no unwanted gas or air inclusion occurs in the examination area 17 or in the sample area 2 supplied to the examination area 17.
- the vent is preferably also by groove-like or groove-like depressions and / or openings or the like. formed in the carrier 7 and / or, if necessary, in the cover 8.
- the connecting chamber 19 preferably serves primarily only for venting and therefore has a preferably only minimal volume.
- Fig. 3 make one Fig. 2 Some aspects, such as the optional venting and the possible protuberances 16 of the cover 8 in the discharge areas 13, 15 and chamber 4, have been omitted, but can be realized accordingly.
- the two channels 12, 14 are connected to separate examination areas 17 and 21.
- the device 1 thus has, in addition to the (first) examination area 17, a further or additional examination area 21, which is supplied with sample fluid 2 by the second passage 14.
- connection line 18 or connection chamber 19 may also be connected to a further separate examination area 21 in addition to the examination area 17 in order to separate or divide the sample liquid 2 removed from the chamber 4 again after the channels 12, 14 have been combined.
- the device 1 is in particular a microfluidic device.
- the volumes of the device 1 or individual or all microfluidic structures, such as the chamber 4, the channels 12, 14, the connecting line 18, the connecting chamber 19 and / or the examination areas 17, 21 are preferably less than 1 ml, in particular less than 500 .mu.m, more preferably substantially 100 .mu.l or less.
- the volume of the channels 12, 14 is in each case preferably less than 20%, in particular less than 10%, of the volume of the chamber 4.
- the preferred derivation of the sample liquid 2 from the chamber 4 on the other hand in cross section small, but several channels 12, 14 has the advantage that even with minimal volume of the chamber 4, in particular minimum chamber height or possibly little or no microstructuring of the chamber 4 or of the chamber bottom 5 for minimizing the dead volume, a good throughput or a high separation efficiency can be achieved.
- a treatment and in particular examination of the sample liquid 2 can take place even in the event of failure or obstruction of a channel 12 or 14, when the two channels 12, 14 are fluidically connected to a common examination area.
- the use of a plurality of channels 12, 14 can also achieve a faster filling of the examination areas 17 and 21 compared to the prior art.
- the channels 12 and 14 preferably extend at least substantially in the main extension plane of the chamber 4 or the carrier 7 and / or in a plane parallel thereto.
- the device 1 can in particular for examining the sample liquid 2 or for determining an analyte in the sample liquid 2 or the like. be used.
- the device 1 for realizing a Imuno assay reaction or the like serve.
- the device 1 can serve for the determination or analysis of specific analytes or other values of the sample liquid 2.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Sampling And Sample Adjustment (AREA)
Description
Die vorliegende Erfindung betrifft eine Vorrichtung zur Behandlung und vorzugsweise Untersuchung von Probenflüssigkeit, insbesondere Blut, gemäß dem Oberbegriff des Anspruchs 1 sowie ein derartiges Verfahren.The present invention relates to a device for the treatment and preferably examination of sample liquid, in particular blood, according to the preamble of
Die vorliegende Erfindung befaßt sich insbesondere mit mikrofluidischen Systemen bzw. Vorrichtungen. Die nachfolgenden Ausführungen beziehen sich daher insbesondere auf Vorrichtungen, bei denen Kapillarkräfte wirken und insbesondere für die Funktion entscheidend sind.The present invention is particularly concerned with microfluidic systems and devices. The following explanations therefore relate in particular to devices in which capillary forces act and, in particular, are decisive for the function.
Es sind Vorrichtungen bekannt, bei denen Blut als Probenflüssigkeit mittels einer flächigen Trenneinrichtung gefiltert wird. Das Filtrat bzw. das Permeat wird in einer sich flachseitig an die Trenneinrichtung anschließenden Kammer aufgenommen und seitlich über einen sich anschließenden Kanal abgeführt. Üblicherweise weist der Kanal einen gegenüber der Kammer wesentlich kleineren Querschnitt auf. Es ist auch bekannt, die Kammer unter der Trenneinrichtung mit fluidischen Strukturen, wie Säulen o.dgl., zu versehen, um eine möglichst gleichmäßige Verteilung und dementsprechend gute Abführung oder Ableitung über den Kanal zu erreichen. Derartige fluidische Strukturen sind jedoch im Hinblick auf ein ungleich größeres Totvolumen nachteilig.Devices are known in which blood is filtered as sample liquid by means of a flat separating device. The filtrate or the permeate is taken up in a chamber which adjoins the separator on the flat side and is discharged laterally via a connecting channel. Usually, the channel has a relation to the chamber substantially smaller cross-section. It is also known to provide the chamber under the separator with fluidic structures, such as columns or the like, in order to achieve the most uniform distribution and accordingly good discharge or discharge via the channel. However, such fluidic structures are disadvantageous in terms of a much larger dead volume.
Ähnliche Vorrichtungen zur Bluttrennung sind beispielsweise aus der
Die
Die
Versuche haben gezeigt, dass selbst wenn sich der Kanal bis in die Mitte der Kammer bzw. unter die Trenneinrichtung erstreckt, bei möglichst geringer Kammerhöhe, also bei möglichst geringem Abstand zur Trenneinrichtung und dementsprechend geringem Totvolumen keine sehr gleichmäßige Ableitung aus der Kammer unter der Trenneinrichtung erfolgt. Vielmehr setzen sich im Wesentlichen nur im Bereich des Kanals die Poren der Trenneinrichtung mit Blutzellen oder sonstigen herausgefilterten Bestandteilen zu. Dementsprechend wird ein optimaler Durchsatz, insbesondere bei Kapillarkraft getriebenen Vorgängen nicht erreicht.Experiments have shown that even if the channel extends to the middle of the chamber or under the separator, at the lowest possible chamber height, ie the smallest possible distance to the separator and correspondingly low dead volume is not very uniform discharge from the chamber under the separator , Rather, essentially only in the region of the channel, the pores of the separation device are filled with blood cells or other components filtered out. Accordingly, an optimal throughput, especially in capillary force driven operations is not achieved.
Der vorliegenden Patentanmeldung liegt die Aufgabe zugrunde, eine Vorrichtung und ein Verfahren zur Behandlung und vorzugsweise Untersuchung von Probenflüssigkeit, insbesondere Blut, anzugeben, wobei eine Optimierung des fluidischen Durchsatzes auf einfache Weise und/oder unter Vermeidung eines übermäßig erhöhten Totvolumens ermöglicht wird.The present patent application is based on the object of specifying a device and a method for the treatment and preferably examination of sample liquid, in particular blood, wherein an optimization of the fluidic throughput is made possible in a simple manner and / or while avoiding an excessively increased dead volume.
Die obige Aufgabe wird durch eine Vorrichtung gemäß Anspruch 1 gelöst. Vorteilhafte Weiterbildungen sind Gegenstand der Unteransprüche.The above object is achieved by a device according to
Eine grundlegende Idee der vorliegenden Erfindung liegt darin, die Probenflüssigkeit aus der sich an der Trenneinrichtung abströmseitig - insbesondere unmittelbar und/oder flachseitig - anschließenden Kammer nicht nur über einen, sondern mindestens über zwei Kanäle und dementsprechend nicht nur über einen, sondern über mindestens zwei seitliche Abflussbereiche abzuleiten. So kann auf einfache Weise und/oder bei minimaler Erhöhung des Totvolumens ein wesentlich höherer Durchsatz bzw. eine wesentlich größere Menge an Probenflüssigkeit abgeleitet werden. Dies lässt sich insbesondere dadurch erklären, dass eine bessere Ableitung aus verschiedenen Bereichen der im Wesentlichen flachen bzw. flächigen Kammer und damit auch aus verschiedenen Bereichen der flächigen Trenneinrichtung erfolgt. Dementsprechend wird die Durchlässigkeit der Trenneinrichtung für die Probenflüssigkeit in einem größeren Bereich besser ausgenutzt, als dies ansonsten bei der Ableitung über nur bei einem Kanal mit kleinem Querschnitt der Fall ist.A basic idea of the present invention is that the sample liquid from the downstream of the separator - especially directly and / or flat - subsequent chamber not only one, but at least two channels and accordingly not only one, but at least two lateral Derive drainage areas. Thus, in a simple manner and / or with a minimal increase in the dead volume, a significantly higher throughput or a significantly larger amount be derived on sample liquid. This can be explained in particular by the fact that a better discharge from different areas of the substantially flat or planar chamber and thus also from different areas of the areal separator takes place. Accordingly, the permeability of the sample liquid separator is better utilized over a wider range than is otherwise the case with only a small channel channel.
Die von den beiden Kanälen abgeleitete Probenflüssigkeit, also die durch die Trenneinrichtung gefilterte Probenflüssigkeit, wie Blutplasma oder Blutserum, kann dann beispielsweise einem gemeinsamen Untersuchungsbereich oder alternativ zwei separaten Untersuchungsbereichen zugeführt werden. Im erstgenannten Fall erfolgt vorzugsweise eine Zusammenführung der Kanäle in einer Verbindungskammer oder Verbindungsleitung, die besonders bevorzugt entlüftet wird, um unerwünschte Gas- bzw. Lufteinflüsse, insbesondere bei sich unterschiedlich schnell füllenden Kanälen, zu vermeiden.The sample liquid derived from the two channels, that is to say the sample liquid filtered by the separating device, such as blood plasma or blood serum, can then be supplied, for example, to a common examination area or alternatively to two separate examination areas. In the former case, the channels are preferably brought together in a connecting chamber or connecting line, which is particularly preferably vented in order to avoid undesired gas or air influences, in particular in the case of channels filling at different rates.
Weitere Vorteile, Merkmale, Eigenschaften und Aspekte der vorliegenden Erfindung ergeben sich aus den Ansprüchen und der folgenden Beschreibung bevorzugter Ausführungsformen anhand der Zeichnung. Es zeigt:
- Fig. 1
- einen schematischen Schnitt einer vorschlagsgemäßen Vorrichtung;
- Fig. 2
- eine schematische Draufsicht eines Trägers der vorschlagsgemäßen Vorrichtung gemäß einer ersten Ausführungsform; und
- Fig. 3
- eine schematische Draufsicht eines Trägers der vorschlagsgemäßen Vorrichtung gemäß einer zweiten Ausführungsform.
- Fig. 1
- a schematic section of a proposed device;
- Fig. 2
- a schematic plan view of a carrier of the proposed device according to a first embodiment; and
- Fig. 3
- a schematic plan view of a carrier of the proposed device according to a second embodiment.
In den Figuren werden für gleiche oder ähnliche Teile dieselben Bezugszeichen verwendet, wobei entsprechende oder vergleichbare Eigenschaften und Vorteile erreicht werden, auch wenn eine wiederholte Beschreibung weggelassen ist.In the figures, the same reference numerals are used for the same or similar parts, and corresponding or comparable properties and advantages are achieved, even if a repeated description is omitted.
Die Vorrichtung 1 weist eine flächige Trenneinrichtung 3 zur Behandlung der Probenflüssigkeit 2, insbesondere zur Abtrennung von Bestandteilen, wie Partikeln oder Zellen, aus der Probenflüssigkeit 2, auf. Insbesondere dient die Trenneinrichtung 3 der Filterung. Sie weist vorzugsweise ein Filterelement, eine Membran o.dgl. auf. Die Trenneinrichtung 3 kann ein- oder mehrschichtig aufgebaut sein. Sie ist vorzugsweise flach oder flächig ausgebildet.The
Besonders bevorzugt ist die Trenneinrichtung 3 durch eine Membran, wie in der
Die Vorrichtung 1 weist eine Kammer 4 zur Aufnahme von durch die Trenneinrichtung 3 geströmter Probenflüssigkeit 2 auf. Insbesondere nimmt die Kammer 4 also durch die Trenneinrichtung 3 behandelte bzw. gefilterte Probenflüssigkeit 2, wie Blutplasma oder Blutserum, auf.The
Die Kammer 4 schließt sich vorzugsweise flachseitig und unmittelbar an die Trenneinrichtung 3 abströmseitig an. Insbesondere ist die Kammer 4 unter der Trenneinrichtung 3 angeordnet. Beim Darstellungsbeispiel ist die Trenneinrichtung 3 flächig größer als die Kammer 4 ausgebildet. Insbesondere ragt die Trenneinrichtung 3 seitlich über die Kammer 4 hinaus, beim Darstellungsbeispiel besonders bevorzugt allseitig.The
Besonders bevorzugt ist die Probenflüssigkeit 2 in der Kammer 4 seitenwandfrei geführt. Dies wird beim Darstellungsbeispiel insbesondere dadurch erreicht, dass sich an einen Boden 5 der Kammer 4 seitlich ein Kapillarstopp anschließt, der besonders bevorzugt durch einen umlaufenden bzw. sich seitlich anschließenden Graben 6 gebildet ist. Jedoch sind auch andere konstruktive Lösungen möglich.Particularly preferably, the
Beim Darstellungsbeispiel ist die Kammer 4 insbesondere zwischen dem Boden 5 der Kammer 4 einerseits und dem gegenüberliegenden Bereich der Trenneinrichtung 3 gebildet. Aufgrund des geringen Abstands dieser beiden gegenüberliegenden Flächen wird die Probenflüssigkeit 2 in der Kammer 4 durch Kapillarkräfte vorzugsweise seitenwandfrei gehalten. Die Kapillarkräfte bzw. der Kapillarstopp verhindern, dass die Probenflüssigkeit 2 in den sich beim Darstellungsbeispiel seitlich anschließenden Graben 6 strömt. Insbesondere bildet der Graben 6 durch seine abrupte Querschnittsvergrößerung - also seine größere Tiefe gegenüber der Kammerhöhe (Abstand des Bodens 5 von der Trenneinrichtung 3) - den Kapillarstopp.In the illustrated example, the
Die Vorrichtung 1 weist beim Darstellungsbeispiel vorzugsweise einen Träger 7, eine zugeordnete Abdeckung 8 und/oder ein Aufnahmeelement 9 auf.In the exemplary embodiment, the
Der Träger 7 ist vorzugsweise plattenartig und/oder starr ausgebildet.The
Der Träger 7 ist vorzugsweise aus Kunststoff und/oder durch Spritzgießen hergestellt. Der Träger 7 weist vorzugsweise mikrofluidische Strukturen für die Probenflüssigkeit 2 und/oder Entlüftungsstrukturen o.dgl. auf, worauf später noch näher eingegangen wird. Diese Strukturen sind vorzugsweise - zumindest teilweise - durch die Abdeckung 8 abgedeckt.The
Die Abdeckung 8 ist vorzugsweise aus Kunststoff hergestellt und/oder als Folie ausgeführt. Die Abdeckung 8 ist vorzugsweise auf den Träger 7 auflaminiert oder aufgeklebt oder in sonstiger Weise damit verbunden.The
Die Abdeckung 8 erstreckt sich vorzugsweise zumindest im Wesentlichen vollflächig oder durchgängig über den Träger 7.The
Das Aufnahmeelement 9 dient vorzugsweise einer Halterung der Trenneinrichtung 3 und/oder einer Aufnahme der Probenflüssigkeit 2, wie eines Bluttropfens, wie in
Die Trenneinrichtung 3 kann beispielsweise in einer Ringschulter o.dgl. am Aufnahmeelement 9 gehalten sein.The
Die Trenneinrichtung 3 ist beispielsweise durch Kleben, Klemmen und/oder Schweißen oder auf jede sonstige geeignete Art und Weise mit dem Aufnahmeelement 9 und/oder dem Träger 7 oder der Abdeckung 8 verbunden bzw. davon gehalten.The
Beim Darstellungsbeispiel ist das Aufnahmeelement 9 auf der Abdeckung 8 angeordnet bzw. mit dieser verbunden. Jedoch kann das Aufnahmeelement 9 auch mit dem Träger 7 direkt verbunden und/oder von diesem gebildet sein.In the illustrated example, the receiving
Um eine seitliche Entlüftung der Kammer 4 zu erreichen, ist der Graben 6 über einen Entlüftungskanal 11 an die Umgebung angeschlossen. Der Entlüftungskanal 11 ist im Träger 7 gebildet.In order to achieve a lateral venting of the
Bei der vorliegenden Beschreibung wird die durch die Trenneinrichtung 3 geströmte bzw. gefilterte Probenflüssigkeit 2 auch als Probenflüssigkeit 2 bezeichnet. In
Die Vorrichtung 1 weist einen ersten Kanal 12 auf, der sich in einem ersten Abflussbereich 13 seitlich an die Kammer 4 anschließt. Die Vorrichtung 1 weist weiter mindestens einen zweiten Kanal 14 auf, der sich in einem zweiten Abflussbereich 15 seitlich an die Kammer 4 anschließt.The
Die Vorrichtung 1 weist also mehrere Kanäle 12, 14 und Abflussbereiche 13, 15 zur Ableitung von Probenflüssigkeit 2 aus der Kammer 4 auf.The
Die Kanäle 12, 14 weisen einen gegenüber der Kammer 4 einen wesentlichen kleineren Querschnitt auf. Die Kanäle 12, 14 weisen vorzugsweise jeweils einen minimalen oder mittleren Querschnitt bzw. einen Querschnitt im Bereich des jeweiligen Abflussbereichs 13/15 auf, der weniger als 20 %, vorzugsweise weniger als 15 %, insbesondere weniger als 10 %, besonders bevorzugt weniger als 5 % des maximalen Querschnitts der Kammer 4 beträgt. Maximaler Querschnitt der Kammer 4 ist hier insbesondere als Produkt aus Kammerhöhe mit dem mittleren oder maximalen Durchmesser des Bodens 5 zu verstehen.The
Die Kanäle 12, 14 bzw. Abflussbereiche 13, 15 sind vorzugsweise an der Kammer 4 randseitig versetzt bzw. auf entgegengesetzten Seiten angeordnet oder angeschlossen. Dementsprechend erfolgt die Ableitung von Probenflüssigkeit 2 aus der Kammer 4 aus unterschiedlichen Bereichen bzw. an unterschiedlichen Stellen, wodurch der Durchsatz der Vorrichtung 1 bzw. die Trenn- oder Filterleistung der Vorrichtung 1 bzw. der Trenneinrichtung 3 auf überraschend einfache Weise wesentlich erhöht werden kann, wie bereits eingangs erläutert.The
Selbstverständlich können auch mehr als zwei Kanäle und Abflussbereiche zur Ableitung von Probenflüssigkeit 2 aus der Kammer 4 an die Kammer 4 seitlich angeschlossen sein. So kann der Durchsatz bzw. die Ableitung von Probenflüssigkeit 2 weiter erhöht werden. Beispielsweise ist eine kreuzartige Anordnung von vier Kanälen und Abflussbereichen an der Kammer 4 möglich.Of course, more than two channels and drainage areas for the discharge of
Die Kanäle 12, 14 erstrecken sich über die Abflussbereiche 13, 15, besonders bevorzugt bis in die Kammer 4 oder den Boden 5 hinein und/oder unter der Trenneinrichtung 3. Insbesondere enden die Kanäle 12, 14 zur Trenneinrichtung 3 hin offen in ihrem jeweiligen Endbereich. Die die Kanäle 12, 14 ansonsten abdeckende Abdeckung 8 kann sich bedarfsweise ebenfalls, insbesondere zungenartig, in oder über die Abflussbereiche 13, 15 und/oder in die Kammer 4 bzw. über den Boden 5 erstrecken, insbesondere also zungenartige Ausstülpungen 16 bilden, wie in
Die Kanäle 12, 14 erstrecken sich zumindest im Wesentlichen bis in die Mitte der Kammer 4 bzw. im Boden 5 miteinander verbunden sein, wie in
Beim Darstellungsbeispiel weist die Vorrichtung 1 einen vorzugsweise kammerartigen Untersuchungsbereich 17 zur Untersuchung von aus der Kammer 4 abgeleiteter Probenflüssigkeit 2 auf. Zur Zuführung von Probenflüssigkeit 2 von der Kammer 4 in den Untersuchungsbereich 17 sind beim Darstellungsbeispiel sowohl der erste Kanal 12 als auch der zweite Kanal 14 fluidisch an den Untersuchungsbereich 17 angeschlossen. Dies kann wahlweise direkt erfolgen oder optional über eine Verbindungsleitung 18 und/oder eine Verbindungskammer 19, wie in
In the illustrated example, the
Beim Darstellungsbeispiel vereinigen sich die beiden Kanäle 12 und 14 zunächst und die aus der Kammer 4 abgeleitete Probenflüssigkeit 2 wird dann über die gemeinsame Verbindungsleitung 18 an den Untersuchungsbereich 17 weitergeleitet. An der Vereinigung der beiden Kanäle 12 und 14 bzw. beim Übergang zur Verbindungsleitung 18 ist vorzugsweise die optionale Verbindungskammer 19 gebildet. Wie gesagt, diese ist aber auch nur optional und kann bedarfsweise entfallen.In the illustrated example, the two
Vorzugsweise ist eine Entlüftung für den Untersuchungsbereich 17 und/oder für die Verbindungsleitung 18 und/oder Verbindungskammer 19 vorgesehen. Die Entlüftung von Verbindungsleitung 18 bzw. Verbindungskammer 19 erfolgt beim Darstellungsbeispiel vorzugsweise durch einen Entlüftungskanal 20, der beispielsweise direkt oder indirekt mit der Umgebung verbunden und/oder in Gasaustausch stehen kann und/oder mit dem Untersuchungsbereich 17 und/oder Graben 6 zur Entlüftung bzw. in Verbindung stehen kann.Preferably, a vent for the
Die vorgesehene Entlüftung ist vorzugsweise derart gestaltet, dass auch bei unterschiedlich schnellem Füllen der Kanäle 12, 14 mit aus der Kammer 4 abgeleiteter Probenflüssigkeit 2 möglichst kein unerwünschter Gas- oder Lufteinschluss in dem Untersuchungsbereich 17 bzw. in der dem Untersuchungsbereich 17 zugeführten Probenflüssigkeit 2 erfolgt.The venting provided is preferably designed such that, even with differently fast filling of the
Die Entlüftung ist vorzugsweise ebenfalls durch rillenartige oder nutartige Vertiefungen und/oder Durchbrechungen o.dgl. im Träger 7 und/oder bedarfsweise in der Abdeckung 8 gebildet.The vent is preferably also by groove-like or groove-like depressions and / or openings or the like. formed in the
Die Verbindungskammer 19 dient vorzugsweise primär nur der Entlüftung und weist daher ein vorzugsweise nur minimales Volumen auf.The connecting
Nachfolgend wird anhand von
Bei der zweiten Ausführungsform sind die beiden Kanäle 12, 14 an separate Untersuchungsbereiche 17 und 21 angeschlossen. Die Vorrichtung 1 weist also zusätzlich zu dem (ersten) Untersuchungsbereich 17 einen weiteren bzw. zusätzlichen Untersuchungsbereich 21 auf, der von dem zweiten Kanal 14 mit Probenflüssigkeit 2 versorgt wird.In the second embodiment, the two
Die beiden Ausführungsformen bzw. einzelne Aspekte davon können auch beliebig miteinander kombiniert werden. Beispielsweise kann die Verbindungsleitung 18 oder Verbindungskammer 19 auch zusätzlich zu dem Untersuchungsbereich 17 an einen weiteren separaten Untersuchungsbereich 21 angeschlossen sein, um die aus der Kammer 4 abgeführte Probenflüssigkeit 2 nach der Vereinigung der Kanäle 12, 14 also wieder aufzutrennen bzw. aufzuteilen.The two embodiments or individual aspects thereof can also be combined with one another as desired. For example, the
Alternativ oder zusätzlich ist es auch möglich, dass beispielsweise vier Kanäle die Probenflüssigkeit 2 aus der Kammer 4 ableiten und in Paaren sich vereinigen, um dann die Probenflüssigkeit 2 der separaten Untersuchungsbereiche 17 und 21 zuzuführen.Alternatively or additionally, it is also possible, for example, for four channels to derive the
Generell ist zu der vorliegenden Erfindung und zu beiden Ausführungsformen folgendes anzumerken:
Bei der Vorrichtung 1 handelt es sich insbesondere um eine mikrofluidische Vorrichtung.In general, the following should be noted with respect to the present invention and to both embodiments:
The
Die Volumina der Vorrichtung 1 bzw. einzelner oder aller mikrofluidischer Strukturen, wie der Kammer 4, der Kanäle 12,14, der Verbindungsleitung 18, der Verbindungskammer 19 und/oder der Untersuchungsbereiche 17, 21, betragen vorzugsweise weniger als 1 ml, insbesondere weniger als 500 µml, besonders bevorzugt im Wesentlichen 100 µml oder weniger.The volumes of the
Das Volumen der Kanäle 12, 14 beträgt jeweils vorzugsweise weniger als 20 %, insbesondere weniger als 10 %, des Volumens der Kammer 4.The volume of the
Die bevorzugte Ableitung der Probenflüssigkeit 2 aus der Kammer 4 über demgegenüber im Querschnitt kleine, jedoch mehrere Kanäle 12, 14 hat den Vorteil, dass auch bei minimalem Volumen der Kammer 4, insbesondere minimaler Kammerhöhe bzw. allenfalls geringer oder gar keiner Mikrostrukturierung der Kammer 4 bzw. des Kammerbodens 5 zur Minimierung des Totvolumens, ein guter Durchsatz bzw. eine hohe Trennleistung erreichbar ist. Alternativ oder zusätzlich kann selbst bei Ausfall oder Verstopfung eines Kanals 12 oder 14 eine Behandlung und insbesondere Untersuchung der Probenflüssigkeit 2 erfolgen, wenn die beiden Kanäle 12, 14 fluidisch an einen gemeinsamen Untersuchungsbereich angeschlossen sind. Bei Ableitung in separate Untersuchungsbereiche 17 und 21 kann durch den Einsatz mehrerer Kanäle 12, 14 ebenfalls ein schnelleres Füllen der Untersuchungsbereiche 17 und 21 gegenüber dem Stand der Technik erreicht werden.The preferred derivation of the
Die Kanäle 12 und 14 erstrecken sich vorzugsweise zumindest im Wesentlichen in der Haupterstreckungsebene der Kammer 4 bzw. des Trägers 7 und/oder in einer dazu parallelen Ebene.The
Die Vorrichtung 1 kann insbesondere zur Untersuchung der Probenflüssigkeit 2 bzw. zur Bestimmung eines Analyts in der Probenflüssigkeit 2 o.dgl. verwendet werden. Beispielsweise kann die Vorrichtung 1 zur Realisierung einer Imuno-Assay-Reaktion o.dgl. dienen. Beispielsweise kann die Vorrichtung 1 der Bestimmung oder Analyse von bestimmten Analyten oder sonstigen Werten der Probenflüssigkeit 2 dienen.The
- 11
- Vorrichtungcontraption
- 22
- Probenflüssigkeitsample liquid
- 33
- Trenneinrichtungseparator
- 44
- Kammerchamber
- 55
- Bodenground
- 66
- Grabendig
- 77
- Trägercarrier
- 88th
- Abdeckungcover
- 99
- Aufnahmeelementreceiving element
- 1010
- Aufnahmebereichreception area
- 1111
- Entlüftungskanalvent channel
- 1212
- erster Kanalfirst channel
- 1313
- erster Abflussbereichfirst drainage area
- 1414
- zweiter Kanalsecond channel
- 1515
- zweiter Abflussbereichsecond drainage area
- 1616
- Ausstülpungprotuberance
- 1717
- Untersuchungsbereichstudy area
- 1818
- Verbindungsleitungconnecting line
- 1919
- Verbindungskammerconnecting chamber
- 2020
- Entlüftungskanalvent channel
- 2121
- zusätzlicher Untersuchungsbereichadditional examination area
Claims (13)
- Device (1) for treatment and preferably for examination of liquid samples (2), in particular blood, with a carrier (7)
with a planar separating device (3),
with a downstream chamber (4) connected to a planar side of the separating device (3) for receiving the liquid samples (2) flowing through the separating device (3), with the chamber (4) arranged under the separating device (3) and the separating device (3) formed with a larger surface area than the chamber (4),
with a first channel (12) and a second channel (14) connected to a side of the chamber (4) in a first drainage area (13) and a second drainage area (15) and which feature a smaller cross-section compared with the chamber (4), and
with an examination area (17) to which the initial channel (12) and/or the second channel (14) is fluidly connected in order to direct liquid samples (2) from the chamber (4) to the examination area (17),
characterised in that
a capillary stop in the form of a segment-like surrounding trench (6) is connected laterally to a floor (5) of the chamber (4), with the trench connected to the surrounding area via a venting channel (11) in the carrier (7), and
the drainage areas (13, 15) form plank-like or bridge-like connections over the trench (6) to the chamber (4) and the channels (12, 14) extend over the drainage areas (13, 15) to the centre of the chamber (4). - Device of claim 1 characterised in that the second channel (14) is fluidly connected to the examination area (17) together with the channel (12) in order to direct liquid samples (2) from the chamber (4) to the examination area (17).
- Device of claim 1 or 2 characterised in that the mechanism features a connection pipe (18) and/or a connection chamber (19) to which both channels (12, 14) are fluidly connected.
- Device of claim 3 characterised in that the mechanism features ventilation for the connection pipe (18) or connection chamber (19).
- Device of claim 3 or 4 characterised in that the connection pipe (18) or connection chamber (19) is connected to the examination area (17) for the supply of liquid samples (2).
- Device of claim 1 characterised in that the second channel (12) is fluidly connected to a separate additional examination area (21) in order to direct liquid samples (2) from the chamber (4) to the additional examination area (21).
- Device of one of the preceding claims characterised in that both drainage areas (13, 15) are arranged or connected to the chamber (4) offset at the edge.
- Device of one of the preceding claims characterised in that both drainage areas (13, 15) are arranged or connected to the chamber (4) on opposite sides.
- Device of one of the preceding claims characterised in that both channels (12, 14) extend under the separating device (3).
- Device of one of the preceding claims characterised in that both channels (12, 14) are formed with recesses, especially notch-like or groove-like ones, in a floor (5) of the chamber (4) and/or in the drainage areas (13, 15).
- Device of claim 10 characterised in that a cover (8), especially a tongue-like one, is used to cover the drainage areas (13, 15) and/or extends under the separating device (3) and covers the channels (12, 14) there.
- Device of one of the preceding claims characterised in that both channels (12, 14) are at least partly formed with recesses, especially notch-like or groove-like ones, in a carrier (7) for the device (1) covered by a cover (8).
- Device of one of the preceding claims characterised in that both channels (12, 14) are connected to each other under the separating device (3).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11730285.1A EP2598242B1 (en) | 2010-07-27 | 2011-07-05 | Apparatus for separating components of a sample liquid |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10007768 | 2010-07-27 | ||
PCT/EP2011/061307 WO2012019829A1 (en) | 2010-07-27 | 2011-07-05 | Apparatus and method for separating components of a sample liquid |
EP11730285.1A EP2598242B1 (en) | 2010-07-27 | 2011-07-05 | Apparatus for separating components of a sample liquid |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2598242A1 EP2598242A1 (en) | 2013-06-05 |
EP2598242B1 true EP2598242B1 (en) | 2018-11-14 |
Family
ID=43427676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11730285.1A Active EP2598242B1 (en) | 2010-07-27 | 2011-07-05 | Apparatus for separating components of a sample liquid |
Country Status (4)
Country | Link |
---|---|
US (1) | US8974751B2 (en) |
EP (1) | EP2598242B1 (en) |
JP (1) | JP5850373B2 (en) |
WO (1) | WO2012019829A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP1530328S (en) * | 2015-02-17 | 2015-08-03 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5135719A (en) * | 1986-10-29 | 1992-08-04 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
US4753776A (en) * | 1986-10-29 | 1988-06-28 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
WO2003093836A1 (en) * | 2002-04-30 | 2003-11-13 | Arkray, Inc. | Analysis instrument, sample analysis method and analysis device using the instrument, and method of forming opening in the instrument |
DE102004027422A1 (en) | 2004-06-04 | 2005-12-29 | Boehringer Ingelheim Microparts Gmbh | Device for receiving blood and separating blood components |
US7682817B2 (en) | 2004-12-23 | 2010-03-23 | Kimberly-Clark Worldwide, Inc. | Microfluidic assay devices |
US8741136B2 (en) * | 2006-02-10 | 2014-06-03 | Boehringer Ingelheim Microparts Gmbh | Device and method for treating or cleaning sample material, in particular nucleic acids |
US7872735B2 (en) | 2007-07-06 | 2011-01-18 | Jds Uniphase Corporation | Method and apparatus for referencing a MEMS device |
JP5475692B2 (en) | 2008-02-27 | 2014-04-16 | ベーリンガー インゲルハイム マイクロパーツ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Plasma separator |
CN101965225B (en) * | 2008-03-11 | 2014-04-30 | 皇家飞利浦电子股份有限公司 | Filtering apparatus for filtering a fluid |
-
2011
- 2011-07-05 JP JP2013521042A patent/JP5850373B2/en active Active
- 2011-07-05 WO PCT/EP2011/061307 patent/WO2012019829A1/en active Application Filing
- 2011-07-05 US US13/811,735 patent/US8974751B2/en active Active
- 2011-07-05 EP EP11730285.1A patent/EP2598242B1/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
EP2598242A1 (en) | 2013-06-05 |
US20130202500A1 (en) | 2013-08-08 |
JP5850373B2 (en) | 2016-02-03 |
WO2012019829A1 (en) | 2012-02-16 |
JP2013535673A (en) | 2013-09-12 |
US8974751B2 (en) | 2015-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2268405B1 (en) | Apparatus for the separation of plasma | |
DE102013203293B4 (en) | Apparatus and method for conducting a liquid through a first or second outlet channel | |
EP2632591B1 (en) | Microfluidic element for analysis of a sample liquid | |
EP2688672A2 (en) | Device and method for filtering blood | |
WO1999046045A1 (en) | Sample support | |
EP2099567A1 (en) | Device for the intake or manipulation of a liquid | |
EP1743690A1 (en) | Filtration unit with multiple vertical filtration modules in row | |
DE10238266A1 (en) | Microfluidic system | |
DE60120829T2 (en) | Floor drain for filter membrane | |
DE102011078770A1 (en) | Microfluidic device, microfluidic system and method of transporting fluids | |
EP2598242B1 (en) | Apparatus for separating components of a sample liquid | |
EP2992324B1 (en) | Sample dispenser for an analytical device | |
EP3144053B1 (en) | Container for a filter cartridge and filter set | |
EP1434637A2 (en) | Method and separating module for the separation of particles from a dispersion, in particular of blood corpuscles from blood | |
DE102013200363A1 (en) | Microfluidic channel system with bubble catcher and method for removing gas bubbles | |
EP2624954A1 (en) | Method for washing a microfluidic cavity | |
EP2729251A1 (en) | Microfluidic structure having recesses | |
EP3201501A1 (en) | Multi-way valve | |
DE4118501C2 (en) | ||
EP2688670B1 (en) | Fluidic system for bubbble-free filling of a microfluidic filter chamber | |
EP2486313B1 (en) | Microfluidic structure and method for positioning a fluid volume in a microfluidic system | |
EP2522427B1 (en) | Micro-fluid device and method for manufacturing the same | |
DE102011111479B4 (en) | filter plate | |
DE102012220250A1 (en) | FLUIDIKMODUL FOR A CENTRIFUGAL FILTRATION AND METHOD FOR FILTERING A SAMPLE | |
WO2021233862A1 (en) | Flow cell with predetermined breaking barrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130227 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20171114 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180814 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1064181 Country of ref document: AT Kind code of ref document: T Effective date: 20181115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502011015007 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20181114 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190214 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190314 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190214 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190314 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190215 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502011015007 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190731 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190731 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190705 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190705 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1064181 Country of ref document: AT Kind code of ref document: T Effective date: 20190705 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190705 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110705 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181114 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230720 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230725 Year of fee payment: 13 Ref country code: DE Payment date: 20230719 Year of fee payment: 13 |